Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Aura Biosciences (AURA) Equity Ratio (2020 - 2026)

Aura Biosciences filings provide 7 years of Equity Ratio readings, the most recent being 0.78 for Q1 2026.

  • Quarterly Equity Ratio fell 5.4% to 0.78 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.78 through Mar 2026, down 5.4% year-over-year, with the annual reading at 0.81 for FY2025, 2.96% down from the prior year.
  • Equity Ratio hit 0.78 in Q1 2026 for Aura Biosciences, down from 0.81 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.96 in Q1 2022 and bottomed at 0.78 in Q1 2026.
  • Average Equity Ratio over 5 years is 0.86, with a median of 0.85 recorded in 2025.
  • The largest annual shift saw Equity Ratio skyrocketed 155.64% in 2022 before it fell 9.68% in 2023.
  • Aura Biosciences' Equity Ratio stood at 0.87 in 2022, then increased by 1.38% to 0.89 in 2023, then dropped by 5.95% to 0.83 in 2024, then fell by 2.96% to 0.81 in 2025, then dropped by 3.6% to 0.78 in 2026.
  • Per Business Quant, the three most recent readings for AURA's Equity Ratio are 0.78 (Q1 2026), 0.81 (Q4 2025), and 0.82 (Q3 2025).